Profile data is unavailable for this security.
About the company
CellSource Co., Ltd. is a Japan-based company engaged in regenerative medicine related business and consumer business. The Company operates in two business segments. The Regenerative Medicine Related business segment is engaged in the provision of contracted services for processing tissues and cells derived from fat and blood to medical institutions, and support services for regenerative medicine laws and regulations related to safety assurance such as regenerative medicine, as well as sales of medical equipment. The Consumer business segment is engaged in the sales of cosmetics and facial products to general consumers.
- Revenue in JPY (TTM)4.45bn
- Net income in JPY622.21m
- Incorporated2015
- Employees151.00
- LocationCellSource Co Ltd11F, Shibuya Cast, 1-23-21, ShibuyaSHIBUYA-KU 150-0002JapanJPN
- Phone+81 364555308
- Fax+81 364555968
- Websitehttps://www.cellsource.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Japan Hospice Holdings Inc | 11.52bn | 560.60m | 11.77bn | 963.00 | 21.28 | 3.65 | 12.51 | 1.02 | 67.19 | 67.19 | 1,383.49 | 392.09 | 0.721 | -- | 6.62 | 11,967,290.00 | 3.51 | 4.43 | 4.15 | 5.29 | 16.35 | 19.68 | 4.86 | 5.49 | -- | 2.78 | 0.8016 | 0.00 | 25.05 | 26.77 | 49.95 | 35.47 | 87.38 | -- |
| Advantage Risk Management Co., Ltd. | 7.22bn | 333.93m | 11.92bn | 439.00 | 35.28 | 3.32 | 11.17 | 1.65 | 19.56 | 19.56 | 437.58 | 207.67 | 0.9466 | -- | 7.07 | 16,438,620.00 | 4.38 | 7.72 | 7.25 | 12.15 | 70.75 | 74.07 | 4.63 | 7.42 | -- | -- | 0.3841 | 40.52 | 9.26 | 7.40 | 33.89 | -3.84 | 36.78 | 3.71 |
| StemCell Institute Inc | 2.64bn | 423.14m | 16.65bn | 98.00 | 39.35 | 5.80 | 30.31 | 6.30 | 41.30 | 41.30 | 257.79 | 280.15 | 0.4039 | 25.62 | 1.67 | 26,953,570.00 | 6.47 | 4.23 | 15.30 | 10.85 | 63.42 | 64.40 | 16.02 | 10.41 | 1.30 | -- | 0.00 | 0.00 | 18.64 | 16.63 | 57.04 | 16.84 | 46.68 | -- |
| Saint-Care Holding Corp | 55.09bn | 1.74bn | 18.28bn | 4.74k | 10.48 | 1.11 | 6.68 | 0.3318 | 69.74 | 69.74 | 2,208.76 | 657.56 | 1.83 | 383.10 | 6.33 | 11,627,200.00 | 5.78 | 5.91 | 7.79 | 7.99 | 12.33 | 12.93 | 3.16 | 3.22 | 2.24 | 20.74 | 0.2347 | 31.53 | 2.86 | 5.63 | 17.04 | 16.58 | -3.20 | 12.30 |
| CellSource Co Ltd | 4.45bn | 622.21m | 22.70bn | 151.00 | 36.29 | 3.68 | 30.79 | 5.11 | 31.58 | 31.58 | 224.78 | 311.55 | 0.7483 | 5.98 | 9.94 | 29,442,380.00 | 10.47 | 19.23 | 11.37 | 22.57 | 64.64 | 70.75 | 14.00 | 20.21 | 10.25 | -- | 0.00 | 12.89 | 5.54 | 30.04 | -9.30 | 36.70 | 70.54 | -- |
| Falco Holdings Co Ltd | 43.05bn | 1.83bn | 25.07bn | 1.12k | 13.37 | 0.9317 | 9.02 | 0.5825 | 169.32 | 169.32 | 3,990.49 | 2,428.93 | 1.18 | 17.59 | 7.25 | 38,538,940.00 | 5.02 | 5.79 | 6.41 | 7.95 | 30.27 | 31.28 | 4.25 | 4.66 | 2.29 | -- | 0.0208 | 38.78 | -8.33 | -0.5259 | -26.32 | 20.60 | 0.8937 | 11.70 |
| Cyberdyne Inc | 4.39bn | -1.18bn | 26.11bn | 227.00 | -- | 0.9925 | -- | 5.94 | -5.58 | -5.58 | 20.81 | 191.45 | 0.0873 | 2.22 | 7.75 | 19,352,420.00 | -2.66 | -1.14 | -2.71 | -1.16 | 52.61 | 61.14 | -30.53 | -20.68 | 14.00 | -10.61 | 0.0132 | -- | 32.38 | 20.57 | -395.30 | -- | -22.40 | -- |
| I'rom Group Co Ltd | 17.89bn | 258.00m | 32.03bn | 1.03k | 121.84 | 2.49 | 21.77 | 1.79 | 21.31 | 21.31 | 1,477.81 | 1,044.22 | 0.50 | 13.39 | 5.99 | 17,387,760.00 | 0.721 | 6.94 | 1.10 | 9.87 | 39.63 | 43.17 | 1.44 | 11.34 | 1.15 | 10.21 | 0.5948 | 31.02 | -3.33 | 10.89 | -44.34 | 9.18 | 16.61 | 14.87 |
| Sunwels Co Ltd | 23.37bn | 2.16bn | 33.39bn | 2.44k | 13.35 | 3.83 | 10.87 | 1.43 | 71.01 | 71.01 | 769.17 | 247.45 | 0.8818 | 1,314.16 | 6.09 | 9,597,947.00 | 8.15 | -- | 9.93 | -- | 29.71 | -- | 9.24 | -- | 1.13 | 5.54 | 0.7342 | -- | 55.72 | -- | 159.16 | -- | -- | -- |
Data as of Nov 22 2024. Currency figures normalised to CellSource Co Ltd's reporting currency: Japanese Yen JPY
10.14%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Baillie Gifford & Co.as of 31 Oct 2024 | 519.80k | 2.62% |
| Nomura Asset Management Co., Ltd.as of 07 Nov 2024 | 395.90k | 2.00% |
| Nikko Asset Management Co., Ltd.as of 08 Nov 2024 | 357.10k | 1.80% |
| Daiwa Asset Management Co. Ltd.as of 31 Oct 2024 | 180.90k | 0.91% |
| Meiji Yasuda Asset Management Co. Ltd.as of 14 Aug 2023 | 165.00k | 0.83% |
| Asset Management One Co., Ltd.as of 07 Nov 2024 | 134.10k | 0.68% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 07 Nov 2024 | 77.40k | 0.39% |
| Wellington Management Co. LLPas of 31 Jul 2024 | 76.30k | 0.39% |
| Jackson National Asset Management LLCas of 30 Sep 2024 | 51.10k | 0.26% |
| SBI Asset Management Co., Ltd.as of 22 Jun 2023 | 50.50k | 0.26% |
More ▼
Data from 22 Jan 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
